Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P02511: Variant p.Arg69Cys

Alpha-crystallin B chain
Gene: CRYAB
Feedback?
Variant information Variant position: help 69 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help US The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Arginine (R) to Cysteine (C) at position 69 (R69C, p.Arg69Cys). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and basic (R) to medium size and polar (C) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description: help In CTRCT16; uncertain significance. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 69 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 175 The length of the canonical sequence.
Location on the sequence: help LRPPSFLRAPSWFDTGLSEM R LEKDRFSVNLDVKHFSPEEL The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         LRPPSFLRAPSWFDTGLSEMRLEKDRFSVNLDVKHFSPEEL

Mouse                         LRPPSFLRAPSWIDTGLSEMRLEKDRFSVNLDVKHFSPEEL

Rat                           LRPPSFLRAPSWIDTGLSEMRMEKDRFSVNLDVKHFSPEEL

Pig                           FRPPSFLRAPSWIDTGLSEMRLEKDRFSVNLDVKHFSPEEL

Bovine                        LRPPSFLRAPSWIDTGLSEMRLEKDRFSVNLDVKHFSPEEL

Rabbit                        LRPPSFLRAPSWIDTGLSEMRLEKDRFSVNLDVKHFSPEEL

Sheep                         LRPPSFLRAPSWIDTGLSEVRLEKDRFSVNLDVKHFSPEEL

Chicken                       MRSP-FFRMPSWLETGLSEMRLEKDKFSVNLDVKHFSPEEL

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 175 Alpha-crystallin B chain
Domain 56 – 164 sHSP
Binding site 83 – 83
Site 60 – 60 Susceptible to oxidation
Site 68 – 68 Susceptible to oxidation
Modified residue 59 – 59 Phosphoserine
Beta strand 68 – 70



Literature citations
Mutation analysis of 12 genes in Chinese families with congenital cataracts.
Sun W.; Xiao X.; Li S.; Guo X.; Zhang Q.;
Mol. Vis. 17:2197-2206(2011)
Cited for: VARIANT CTRCT16 CYS-69;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.